Sanaz Asemani

Dr. Sanaz Asemani

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 November 2019 in BMC Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
SPSaeed Pirouzpanah
Saeed Pirouzpanah
SASanaz Asemani
Sanaz Asemani
ASAli Shayanfar
Ali Shayanfar
Behzad BaradaranBehzad Baradaran
Behzad Baradaran
VMVahid Montazeri
Vahid Montazeri
Background: The present study was designed to investigate the effects ofBerberis vulgaris(BV) juice consumption on plasma levels of insulin-like growth factor (IGF-1), IGF-binding proteins (IGFBPs), and the expression ofPPAR-γ,VEGFandHIFin women with benign breast disease.Methods: This parallel design randomized, double-blind controlled clinical trial was conducted on 85 eligible patients diagnosed with benign breast disease. They were assigned randomly into eitherBVjuice group (n = 44, BV juice: 480 ml/day) or placebo group (n = 41,BVplacebo juice: 480 ml/day) for 8 weeks intervention. Participants, caregivers and those who assessed laboratory analyses were blinded to the assignments. Plasma levels of biomarkers were measured at baseline and after 8 weeks by ELISA. Quantitative real-time PCR was used to measure the fold change in the expression of each interested gene.Results: The compliance of participants was 95.2% and 40 available subjects analyzed in each group at last. Relative treatment (RT) effects for BV juice caused 16% fall in IGF-1 concentration and 37% reduction in the ratio of IGF-1/1GFBP1. Absolute treatment effect expressed 111 ng/ml increased mean differences of IGFBP-3 betweenBVgroup and placebo. Plasma level ofPPAR-γincreased in both groups but it was not significant. Fold changes in the expressions ofPPAR-γ,VEGFandHIFshowed down-regulation in the intervention group compared to placebos (P < 0.05).Conclusions: TheBVjuice intervention over 8 weeks was accompanied by acceptable efficacy and decreased plasma IGF-1, and IGF-1/IGFBP-1 ratio partly could be assigned to enhanced IGFBP-1 level in women with BBD. The intervention caused reductions in the expression levels ofPPAR, VEGF,andHIFwhich are remarkable genomic changes to potentially prevent breast tumorigenesis.Trial registration: IRCT2012110511335N2. Registered 10 July 2013 (retrospectively registered).

14 May 2020 in British Journal of Nutrition
Verified
Journal Article
Open access
PDF file
SASanaz Asemani
Sanaz Asemani
VMVahid Montazeri
Vahid Montazeri
MFMitra Foroutan-Ghaznavi
Mitra Foroutan-Ghaznavi
SPSeyed-Sajjad Pirouzpanah
Seyed-Sajjad Pirouzpanah
Behzad BaradaranBehzad Baradaran
Behzad Baradaran
SPSaeed Pirouzpanah
Saeed Pirouzpanah
We aimed to study dietary patterns in association with the relative expression levels of PPAR-γ, vascular endothelial growth factor-A (VEGF-A) and hypoxia-inducible factor-1α (HIF-1α) in women with benign breast disease (BBD). The study design was combinative, included a case-series and case–control compartments. Initially, eligible BBD patients (n 77, aged 19–52 years old) were recruited at Nour-Nejat hospital, Tabriz, Iran (2012–2014). A hospital-based group of healthy controls was matched for age (n 231, aged 20–63 years old) and sex. Dietary data were collected using a valid 136-item FFQ. Principal component analysis generated two main components (Kaiser–Meyer–Olkin = 0·684), including a Healthy pattern (whole bread, fruits, vegetables, vegetable oils, legumes, spices, seafood, low-fat meat, skinless poultry, low-fat dairy products, nuts and seeds) and a Western pattern (starchy foods, high-fat meat and poultry, high-fat dairy products, hydrogenated fat, fast food, salt and sweets). High adherence to the Western pattern increased the risk of BBD (ORadj 5·59; 95 % CI 2·06, 15·10; P < 0·01), whereas high intake of the Healthy pattern was associated with a 74 % lower risk of BBD (95 % CI 0·08, 0·81; P < 0·05). In the BBD population, the Western pattern was correlated with over-expression of HIF-1α (radj 0·309, P < 0·05). There were inverse correlations between the Healthy pattern and expressions of PPAR-γ (radj −0·338, P < 0·05), HIF-1α (radj −0·340, P < 0·05) and VEGF-A (radj −0·286, P < 0·05). In conclusion, new findings suggested that the Healthy pattern was associated inversely with the risk of BBD, and this could be correlated with down-regulation of PPAR-γ, VEGF-A and HIF-1α genes, which might hold promise to preclude BBD of malignant pathological transformation.

2 June 2023 in BMC Women's Health
Verified
Journal Article
Open access
PDF file
EFElnaz Faramarzi
Elnaz Faramarzi
MSMohammd Hossein Somi
Mohammd Hossein Somi
HTHelda Tutunchi
Helda Tutunchi
HAHanieh Almaspour
Hanieh Almaspour
SSSarvin Sanaie
Sarvin Sanaie
SASanaz Asemani
Sanaz Asemani
We aimed to study the association of parity number with multimorbidity (MM) and polypharmacy among women in the Azar cohort population. This cross-sectional investigation was based on data from the Azar Cohort Study. Information regarding demographics, personal habits, physical activity level, medical and reproductive history, and anthropometric measurements of 8,290 females (35–70 years) were evaluated. Ordinal logistic and logistic regression analyses were conducted to assess for associations of parity number with multimorbidity (MM), polypharmacy, chronic disease, and abdominal obesity. More educated participants and people in the fifth quintile of the Wealth Score Index were less likely to have a higher parity number. With increasing parity numbers, the prevalence of MM, polypharmacy, hypertension, cardiovascular disease, fatty liver disease, stroke, rheumatoid diseases, chronic obstructive pulmonary disease, and cancers tended to rise. Moreover, we found that increasing parity numbers (especially when ≥ 5) enhanced the odds of abdominal obesity, waist-to-hip ratio ≥ 0.85, and waist-to-height ratio ≥ 0.5; these significant associations were more obvious in parity numbers ≥ 9 and WHtR ≥ 0.5. The parity number is associated with MM and polypharmacy in Iranian women enrolled in the Azar Cohort Study. Further studies exploring the pathways (biological, social, and environmental) underlying these relationships will provide clues for preventing morbidity and premature mortality among susceptible andhighly parous women.

8 November 2024 in Prostaglandins & Other Lipid Mediators
Verified
Journal Article
Closed access
JZJuanjuan Zhu
Juanjuan Zhu
BWBingbing Wang
Bingbing Wang
SASanaz Asemani
Sanaz Asemani
SBShiwei Bao
Shiwei Bao
NTNiannian Tian
Niannian Tian